Opinion: STAT readers debate blue zones, open-access publishing fees, and more

STAT's First Opinion platform is soliciting Letters to the Editor to foster discussion on life sciences topics, as evidenced by recent reader engagement. The platform features essays from biotech insiders, healthcare workers, and researchers, aiming to provoke thoughtful debate. Selected letters are published to encourage robust, good-faith discussion on issues raised in the essays. Interested parties can submit their letters via a form available at the end of any First Opinion essay.